GlassScriptPrepare for your visit
Mark B Frisch
Obstetrics & Gynecology · Phila, PA · NPI 1558347625
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,591.24
in general payments reported to CMS, 2019-2025 · $650 in 2025
The $650 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Who reported paying
General payments only, top 6 by amount.
- Becton, Dickinson and Company $695.00
- Innocoll Pharmaceuticals Limited $575.00
- Aspira Women'S Health INC $255.24
- Medtronic, INC. $25.00
- Bayer Healthcare Pharmaceuticals INC. $25.00
- Millicent US INC $16.00
Drugs and devices associated with these payments
Avitene Ultrafoam Bd Introsyte
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Mark Frisch listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/297189/mark-b-frisch